| Literature DB >> 26101775 |
John Hoon Rim1, Yangsoon Lee2, Sung Kuk Hong1, Yongjung Park1, MyungSook Kim1, Roshan D'Souza1, Eun Suk Park3, Dongeun Yong1, Kyungwon Lee1.
Abstract
While pulsed-field gel electrophoresis (PFGE) is recognized as the gold standard method for clonality analysis, MALDI-TOF MS has recently been spotlighted as an alternative tool for species identification. Herein, we compared the dendrograms of multi-drug-resistant (MDR) Acinetobacter baumannii isolates by using MALDI-TOF MS with those by using PFGE. We used direct colony and protein extraction methods for MALDI-TOF MS dendrograms. The isolates with identical PFGE patterns were grouped into different branches in MALDI-TOF MS dendrograms. Among the isolates that were classified as very close isolates in MALDI-TOF MS dendrogram, PFGE band patterns visually showed complete differences. We numeralized similarity among isolates by measuring distance levels. The Spearman rank correlation coefficient values were 0.449 and 0.297 between MALDI-TOF MS dendrogram using direct colony and protein extraction method versus PFGE, respectively. This study is the first paper focusing solely on the dendrogram function of MALDI-TOF MS compared with PFGE. Although MALDI-TOF MS is a promising tool to identify species in a rapid manner, our results showed that MALDI-TOF MS dendrograms could not substitute PFGE for MDR Acinetobacter baumannii clonality analysis.Entities:
Mesh:
Year: 2015 PMID: 26101775 PMCID: PMC4458526 DOI: 10.1155/2015/535027
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Characteristics of the isolates tested and ICU patients.
| Isolate | Type of specimen |
Sputum | Antibiotics (susceptibility/MIC in | Age | Sex |
Major disease condition related to | Underlying major diseases |
Clinical | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
| COL | IMI | CFT | LFX | ||||||||
| 1 | Sputum, endotracheal aspirate | 6 | S ≤ 0.5 | R ≥ 16 | R ≥ 64 | R ≥ 8 | 66 | F | Pneumonia | Chronic kidney disease, septic arthritis | Discharged |
| 2 | Sputum | 6 | S ≤ 0.5 | R ≥ 16 | R ≥ 64 | R ≥ 8 | 62 | F | None | End-stage renal disease | Discharged |
| 3 | Endotracheal aspirate | 6 | S ≤ 0.5 | R ≥ 16 | R ≥ 64 | R ≥ 8 | 67 | M | Pneumonia | Rectosigmoid junction cancer | Expired |
| 4 | Sputum | 6 | S ≤ 0.5 | S ≤ 0.25 | S 8 | R ≥ 8 | 29 | M | None | Anti-NMDA receptor encephalitis | Discharged |
| 5 | Endotracheal aspirate | 6 | S ≤ 0.5 | R ≥ 16 | R ≥ 64 | R ≥ 8 | 67 | M | Pneumonia | Lung cancer | Expired |
| 6 | Endotracheal aspirate | 6 | S ≤ 0.5 | R ≥ 16 | R ≥ 64 | R ≥ 8 | 72 | F | Pneumonia | Myasthenia gravis, pseudomembranous colitis | Discharged |
| 7 | Endotracheal aspirate | 6 | R 16 | R ≥ 16 | R ≥ 64 | R ≥ 8 | 61 | M | Pneumonia | Pancreatic cyst | Expired |
| 8 | Sputum | 5 | S ≤ 0.5 | R ≥ 16 | R ≥ 64 | R ≥ 8 | 49 | F | Pneumonia | Acute lymphoblastic leukemia | Expired |
| 9 | Sputum | 6 | S ≤ 0.5 | R ≥ 16 | R ≥ 64 | R ≥ 8 | 2 | F | Pneumonia | Hypoxic ischemic encephalopathy | Discharged |
| 10 | Endotracheal aspirate | 6 | S ≤ 0.5 | R ≥ 16 | R ≥ 64 | R ≥ 8 | 79 | F | Pleural effusion, tracheostomy | Aortic regurgitation, chronic renal failure | Discharged |
| 11 | Sputum | 6 | S ≤ 0.5 | R ≥ 16 | R ≥ 64 | R ≥ 8 | 75 | M | Interstitial lung disease | Cholangiocarcinoma, upper GI bleeding | Expired |
| 12* | Sputum | 6 | S ≤ 0.5 | R ≥ 16 | R ≥ 64 | R ≥ 8 | 71 | M | Pneumonia | Urinary tract infection, osteomyelitis, invasive aspergillosis | Discharged |
| 13 | Endotracheal aspirate | 6 | S ≤ 0.5 | R ≥ 16 | R ≥ 64 | R ≥ 8 | 49 | M | None | Diffuse large B-cell lymphoma, bacterial meningitis | Expired |
| 14 | Endotracheal aspirate | 6 | S ≤ 0.5 | R ≥ 16 | R ≥ 64 | R ≥ 8 | 71 | M | None | Alzheimer's disease, pneumothorax | Discharged |
| 15 | Endotracheal aspirate | 6 | S ≤ 0.5 | R ≥ 16 | R ≥ 64 | R ≥ 8 | 81 | M | Pneumonia | Chronic renal failure | Expired |
| 16 | Sputum | 6 | S ≤ 0.5 | R ≥ 16 | R ≥ 64 | R ≥ 8 | 74 | M | Pneumonia | Pneumothorax, acute renal failure | Expired |
| 17 | Sputum | 6 | S ≤ 0.5 | R ≥ 16 | R ≥ 64 | R ≥ 8 | 78 | M | Pneumonia | Acute pulmonary edema | Expired |
| 18 | Sputum | 6 | S ≤ 0.5 | R ≥ 16 | R ≥ 64 | R ≥ 8 | 31 | M | Pneumonia | Aplastic anemia, intracranial hemorrhage | Expired |
| 19 | Endotracheal aspirate | 6 | S ≤ 0.5 | R ≥ 16 | I 16 | I 4 | 75 | F | Pneumonia, pleural effusion | Wegener's granulomatosis | Expired |
| 20 | Sputum | 6 | S ≤ 0.5 | R ≥ 16 | I 16 | I 4 | 21 | M | Pneumonia | Cerebral palsy, Dravet syndrome | Discharged |
| 21 | Endotracheal aspirate | 6 | S ≤ 0.5 | R ≥ 16 | R ≥ 64 | R ≥ 8 | 62 | M | Pneumonia | Gas gangrene | Expired |
| 22 | Sputum | 6 | S ≤ 0.5 | R ≥ 16 | R ≥ 64 | R ≥ 8 | 45 | F | Pneumonia | Systemic sclerosis, ovarian cancer | Expired |
| 23 | Sputum | 6 | S ≤ 0.5 | R ≥ 16 | R ≥ 64 | R ≥ 8 | 71 | M | Pneumonia | Esophageal cancer | Discharged |
| 24 | Sputum | 6 | S ≤ 0.5 | R ≥ 16 | R ≥ 64 | I 4 | 70 | M | Pneumonia | Esophageal cancer | Expired |
| 25 | Sputum | 6 | S ≤ 0.5 | R ≥ 16 | R ≥ 64 | R ≥ 8 | 43 | M | Pneumonia | Cerebral palsy, AV block | Discharged |
| 26 | Endotracheal aspirate | 6 | S ≤ 0.5 | R ≥ 16 | R ≥ 64 | R ≥ 8 | 75 | M | Mediastinitis | Cerebrovascular attack, peptic ulcer | Expired |
| 27 | Endotracheal aspirate | 6 | S ≤ 0.5 | R ≥ 16 | R ≥ 64 | I 4 | 69 | F | None | Hypoxic brain damage | Discharged |
| 28 | Sputum | 6 | S ≤ 0.5 | R ≥ 16 | R ≥ 64 | R ≥ 8 | 9 | F | Pneumonia, pleural effusion | Encephalitis | Inpatient |
| 29** | Sputum | 6 | S ≤ 0.5 | R ≥ 16 | R ≥ 64 | R ≥ 8 | 71 | M | Pneumonia | Urinary tract infection, osteomyelitis, invasive aspergillosis | Discharged |
| 30 | Sputum | 4 | R ≥ 16 | R ≥ 16 | R ≥ 64 | R ≥ 8 | 66 | M | Pneumonia | Anaplastic astrocytoma, atrial septal defect | Discharged |
| 31*** | — | — | S ≤ 0.5 | R ≥ 16 | R ≥ 64 | R ≥ 8 | — | — | — | — | — |
| 32*** | — | — | S ≤ 0.5 | R ≥ 16 | R ≥ 64 | R ≥ 8 | — | — | — | — | — |
*Sputum grade is assessed based on a modified Washington and Murray score system.
**Isolates numbers 12 and 29 were collected from the same patient at different times during hospitalization.
***Environment surveillance specimens (monitor cable line between beds).
MIC, minimal inhibitory concentration; COL, colistin; IPM, imipenem; CTX, cefotaxime; LEV, levofloxacin; S, susceptible; R, resistant; I, intermediate.
Figure 1MALDI-TOF MS dendrograms for tested isolates. (a) Comparison between MALDI-TOF MS dendrograms with a cut-off value of 350 using the direct colony method (left) and the protein extraction method (right). (b) MALDI-TOF MS dendrogram of all 64 isolates (32 isolates identified by the two methods) with a cut-off value of 250.
Figure 2Comparison between PFGE (left) and the MALDI-TOF MS dendrogram using the protein extraction method (right).
Figure 3Comparison between PFGE and the MALDI-TOF MS dendrogram using the Spearman rank correlation analysis and dot plots. (a) Comparison between PFGE and the MALDI-TOF MS dendrogram using the direct colony method and (b) comparison between PFGE and the MALDI-TOF MS dendrogram using the protein extraction method. *Statistically significant (P < 0.001).